50228-424Level 3
RANOLAZINE (RANOLAZINE)
**Product type:** Human Prescription Drug
**Active ingredient:** RANOLAZINE
**Strength:** 1000 mg/1
**Dosage form:** Tablet, Film Coated, Extended Release
**Route:** Oral
**Labeler:** ScieGen Pharmaceuticals, Inc
**Marketing category:** ANDA (ANDA211829)
**Pharmacologic class:** Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/50228-424Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.